Johnson & Johnson will have to pay $ 2.1 billion in talc cancer cases after the Supreme Court rejected it

Johnson & Johnson is required to pay $ 2.1 billion to women accused of asbestos cancer in the pharmacist’s baby powder after the U.S. Supreme Court refused to consider the case.

The verdict has been the largest against the company, it has fought a flurry of lawsuits and lost several cases to thousands of people for cancer-causing products. The appeal, which was denied on Tuesday, was related to a case involving 22 women in Missouri in 2018.

“The court’s decision not to review the Ingham case leaves important legal questions for state and federal courts to follow,” J & J said, adding that “decades of independent scientific assessments confirm Johnson’s Baby Powder is safe, not asbestos.” , and does not cause cancer “.

Last year, the company said it would stop selling baby powder fell in the U.S. and Canada after falling 60 percent in three years.

Supreme Court judges upheld Missouri state court ruling ordering J&J to pay $ 4.7 million in compensation, though then that penalty was reduced to $ 2.12 million.

In November, the Missouri state court denied hearing J & J’s appeal, and referred the case to the country’s highest court. The drug perpetrator argued before a single jury that he had gathered several claims related to talcum powder before a single jury that the lawsuit violated J & J’s rights under the U.S. Constitution.

J & J’s share price fell 1.6 percent after it was clarified in New York on Tuesday morning that it would have no choice but to post that argument and would have to pay the premium.

Several large U.S. business groups, including the Business Bureau and the U.S. Chamber of Commerce, sided with the company’s appeal.

Talcum powder is made from the mineral talc, and in its natural form contains asbestos, a substance that can cause cancer. The health industry agreed in 1976 to prevent all talc products from detecting asbestos levels.